Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a Home link. The previous study details and sections appear to be removed.SummaryDifference18%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor refresh of the entry that does not modify study data, eligibility criteria, or results.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer revision. This is a metadata update rather than a substantive change to the study details.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision label updated to v3.6.4, replacing the previous v3.6.3. This indicates a minor maintenance update to the page’s versioning.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new patch/version was applied to the page.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now shows the revision label as v3.6.2, replacing v3.6.0. This appears to be a minor site update and does not affect the study details or other content on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.